Erotic transference in the male adolescent-female analyst dyad / Sarah Atkinson en The psychoanalytic study of the child, Año 1995 - Vol. 50 ([18/06/2020])

Público ISBD [artículo]  inThe psychoanalytic study of the child > Año 1995 - Vol. 50 [18/06/2020] . - pp. 171-186 Título : Erotic transference in the male adolescent-female analyst dyad Tipo de documento: texto impreso Autores: Sarah Atkinson, Autor ; Glen O. Gabbard, Autor Fecha de publicación: 2020 Artículo en la página: pp. 171-186 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Contratransferencia, Relaciones médico-paciente, Terapia psicoanalítica, Comportamiento sexual, Transferencia, Psicología. Resumen: Erotic transference involving female analysts and adult male patients has received increased attention in the past ten years. Absent from the literature, however, are any clinical reports concerning erotic transferences of adolescent male patients with female therapists. Link: ./index.php?lvl=notice_display&id=22823 [artículo] Erotic transference in the male adolescent-female analyst dyad [texto impreso] / Sarah Atkinson, Autor ; Glen O. Gabbard, Autor . - 2020 . - pp. 171-186. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The psychoanalytic study of the child > Año 1995 - Vol. 50 [18/06/2020] . - pp. 171-186 Palabras clave: Contratransferencia, Relaciones médico-paciente, Terapia psicoanalítica, Comportamiento sexual, Transferencia, Psicología. Resumen: Erotic transference involving female analysts and adult male patients has received increased attention in the past ten years. Absent from the literature, however, are any clinical reports concerning erotic transferences of adolescent male patients with female therapists. Link: ./index.php?lvl=notice_display&id=22823

A randomized, double-blind study of once-daily extended release quetiapine fumarate (quetiapine xr) monotherapy in patients with generalized anxiety disorder / Arifulla Khan en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - PP. 418-428 Título : A randomized, double-blind study of once-daily extended release quetiapine fumarate (quetiapine xr) monotherapy in patients with generalized anxiety disorder Tipo de documento: texto impreso Autores: Arifulla Khan, Autor ; Mark Joyce, Autor ; Sarah Atkinson, Autor Fecha de publicación: 2022 Artículo en la página: PP. 418-428 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Agentes ansiolíticos, Agentes antipsicóticos, Ensayo clínico, Fumarato de quetiapina de liberación prolongada, Placebo, Multicéntrico, Estudio de fase 3 Resumen: This study evaluated once-daily, extended-release quetiapine fumarate (quetiapine XR) monotherapy in generalized anxiety disorder (GAD). This was a 10-week (8-week active treatment/2-week posttreatment drug-discontinuation/tapering phase), double-blind, randomized, placebo-controlled study (D1448C00009). Primary end point was change from randomization at week 8 in Hamilton Anxiety Rating Scale (HAM-A) total score. Link: ./index.php?lvl=notice_display&id=29360 [artículo] A randomized, double-blind study of once-daily extended release quetiapine fumarate (quetiapine xr) monotherapy in patients with generalized anxiety disorder [texto impreso] / Arifulla Khan, Autor ; Mark Joyce, Autor ; Sarah Atkinson, Autor . - 2022 . - PP. 418-428. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 4 (Agosto) . - PP. 418-428 Palabras clave: Agentes ansiolíticos, Agentes antipsicóticos, Ensayo clínico, Fumarato de quetiapina de liberación prolongada, Placebo, Multicéntrico, Estudio de fase 3 Resumen: This study evaluated once-daily, extended-release quetiapine fumarate (quetiapine XR) monotherapy in generalized anxiety disorder (GAD). This was a 10-week (8-week active treatment/2-week posttreatment drug-discontinuation/tapering phase), double-blind, randomized, placebo-controlled study (D1448C00009). Primary end point was change from randomization at week 8 in Hamilton Anxiety Rating Scale (HAM-A) total score. Link: ./index.php?lvl=notice_display&id=29360

---

1 (1 - 2 / 2)